The Society of Nuclear Medicine and Molecular Imaging is working with industry partners to push innovation in the space as part of its new Value Initiative Industry Alliance.
A professional society focused on nuclear medicine is launching an effort to drive more collaboration in the corporate world.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), with its new Value Initiative Industry Alliance, will bring together corporate partners to help forge the future of the technology. The alliance, which will welcome both large companies and small startups, builds on the society’s Value Initiative, a long-term strategic plan it adopted last year.
In a news release, SNMMI Vice President Satoshi Minoshima, who chairs the Value Initiative board, noted that the alliance creates an opportunity to strengthen relationships between the society and the industry that supports its work.
“Innovative nuclear medicine and molecular imaging research is beginning to transform precision medicine and patient outcomes,” Minoshima said. “Working together with Alliance participants, which range from small businesses to the largest corporations in the industry, we can advance scientific discoveries and rapidly translate them to patient care with more effective diagnostics and targeted therapy.”
Among the first members of the Alliance are Blue Earth Diagnostics, Siemens Healthineers Molecular Imaging, Jubilant DraxImage, Inc., and Advanced Accelerator Applications.
“We hope, via the Value Initiative, to allow other companies to benefit from and to contribute to the growth of nuclear medicine,” Blue Earth CEO Jonathan Allis said in the release. Allis and Siemens Healthineers Molecular Imaging head James Williams are co-chairing the group.
The industry partners will meet at SNMMI’s annual meeting in Philadelphia this month and plan to replicate the meeting in future years.